The possibility of early diagnosis of AD pathology based on the analysis of Reelin, Aβ1-42, FTH1 and TAU expression in vitreal fluids can be prospected as a starting point for promising diagnostic and therapeutic approaches. The gene discussed is RELN; the disease is Alzheimer disease.